Trials / Conditions / Non-small-cell Lung Cancer Patients

Non-small-cell Lung Cancer Patients

7 registered clinical trials studyying Non-small-cell Lung Cancer Patients — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-c NCT05568212	Fondazione Ricerca Traslazionale	Phase 2
Unknown	Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients NCT04473703	Shanghai Chest Hospital	—
Active Not Recruiting	Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT) NCT03896074	Fondazione Ricerca Traslazionale	Phase 2
Unknown	Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR-B NCT03493581	Assistance Publique Hopitaux De Marseille	N/A
Unknown	Pembrolizumab (MK-3475) as Maintainance in Treated Patients With Unresectable Stage III NSCLC NCT03379441	University of Turin, Italy	Phase 2
Unknown	Analysis of Plasma Tumor DNA in Lung Cancer Patients NCT01930474	Seoul National University Hospital	—
Completed	Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treate NCT02043002	University of Aarhus	N/A